{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T08:34:57Z","timestamp":1778402097269,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmig.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Minimally Invasive Gynecology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jmig.2020.09.020","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T08:15:44Z","timestamp":1602144944000},"page":"403-408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Salpingectomy for the Risk Reduction of Ovarian Cancer: Is It Time for a Salpingectomy-alone Approach?"],"prefix":"10.1016","volume":"28","author":[{"given":"Thomas","family":"Boerner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara","family":"Long Roche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmig.2020.09.020_bib0001","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jmig.2020.09.020_bib0002","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial","volume":"305","author":"Buys","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jmig.2020.09.020_bib0003","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmig.2020.09.020_bib0004","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","article-title":"Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study","volume":"26","author":"Kauff","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmig.2020.09.020_bib0005","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmig.2020.09.020_bib0006","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ygyno.2018.11.033","article-title":"The Fallopian tube, \u201cprecursor escape\u201d and narrowing the knowledge gap to the origins of high-grade serous carcinoma","volume":"152","author":"Soong","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2020.09.020_bib0007","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/modpathol.2016.238","article-title":"Serous tubal intraepithelial neoplasia: the concept and its application","volume":"30","author":"Meserve","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jmig.2020.09.020_bib0008","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/1471-0528.14543","article-title":"Serous tubal intraepithelial carcinomas associated with high-grade serous ovarian carcinomas: a systematic review","volume":"124","author":"Chen","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.jmig.2020.09.020_bib0009","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the Fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jmig.2020.09.020_bib0010","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3390\/cancers10120468","article-title":"Back to the future? The fallopian tube, precursor escape and a dualistic model of high-grade serous carcinogenesis","volume":"10","author":"Soong","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jmig.2020.09.020_bib0011","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jmig.2020.09.020_bib0012","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies [published correction appears in Am J Hum Genet. 2003;73:709]","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jmig.2020.09.020_bib0013","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","article-title":"Inherited mutations in women with ovarian carcinoma","volume":"2","author":"Norquist","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jmig.2020.09.020_bib0014","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ygyno.2017.10.001","article-title":"Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction","volume":"147","author":"Jones","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2020.09.020_bib0015","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Risch","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jmig.2020.09.020_bib0016","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/humu.23406","article-title":"Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations","volume":"39","author":"Rebbeck","year":"2018","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jmig.2020.09.020_bib0017","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases","volume":"104","author":"Pal","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.jmig.2020.09.020_bib0018","unstructured":"National Cancer Institute. NCI dictionary of genetics terms. Available at: https:\/\/www.cancer.gov\/publications\/dictionaries\/genetics-dictionary\/def\/cascade-screening. Accessed August 14, 2020."},{"key":"10.1016\/j.jmig.2020.09.020_bib0019","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.3390\/cancers12071929","article-title":"Economic evaluation of population-based BRCA1\/BRCA2 mutation testing across multiple countries and health systems","volume":"12","author":"Manchanda","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jmig.2020.09.020_bib0020","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jmig.2020.09.020_bib0021","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jmig.2020.09.020_bib0022","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmig.2020.09.020_bib0023","doi-asserted-by":"crossref","first-page":"9","DOI":"10.6004\/jnccn.2017.0003","article-title":"NCCN guidelines insights: genetic\/familial high-risk assessment: breast and ovarian, version 2.2017","volume":"15","author":"Daly","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jmig.2020.09.020_bib0024","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/GIM.0b013e318163487d","article-title":"Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers","volume":"10","author":"Bradbury","year":"2008","journal-title":"Genet Med"},{"key":"10.1016\/j.jmig.2020.09.020_bib0025","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.maturitas.2010.03.018","article-title":"Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1\/2 mutation carriers","volume":"66","author":"Kenkhuis","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/j.jmig.2020.09.020_bib0026","doi-asserted-by":"crossref","first-page":"S312","DOI":"10.1016\/S0002-9378(99)70725-8","article-title":"Vasomotor flushes in menopausal women","volume":"180","author":"Bachmann","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jmig.2020.09.020_bib0027","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00042192-199805030-00010","article-title":"Incidence of sexual dysfunction in surgically menopausal women","volume":"5","author":"Shifren","year":"1998","journal-title":"Menopause"},{"key":"10.1016\/j.jmig.2020.09.020_bib0028","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.maturitas.2011.08.001","article-title":"Quality of life and health status after prophylactic salpingo-oophorectomy in women who carry a BRCA mutation: a review","volume":"70","author":"Finch","year":"2011","journal-title":"Maturitas"},{"key":"10.1016\/j.jmig.2020.09.020_bib0029","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ygyno.2010.12.326","article-title":"The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation","volume":"121","author":"Finch","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2020.09.020_bib0030","first-page":"317","article-title":"Psychological consequences of surgical menopause","volume":"46","author":"Taylor","year":"2001","journal-title":"J Reprod Med"},{"key":"10.1016\/j.jmig.2020.09.020_bib0031","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(19)31709-X","article-title":"Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence","volume":"394","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jmig.2020.09.020_bib0032","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S1470-2045(06)70869-5","article-title":"Survival patterns after oophorectomy in premenopausal women: a population-based cohort study","volume":"7","author":"Rocca","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jmig.2020.09.020_bib0033","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ygyno.2019.09.005","article-title":"Completeness of salpingectomy intended for ovarian cancer risk reduction","volume":"155","author":"Wong","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2020.09.020_bib0034","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1200\/JCO.2016.34.15_suppl.1506","article-title":"Prophylactic salpingectomy with delayed oophorectomy (PSDO): feasibility study in women with BRCA mutations","volume":"34","author":"Nebgen","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmig.2020.09.020_bib0035","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ygyno.2014.12.031","article-title":"de Hullu JAJRisk-reducing salpingectomy with delayed oophorectomy in BRCA1\/2 mutation carriers: patients\u2019 and professionals\u2019 perspectives","volume":"136","author":"Arts-de Jong","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2020.09.020_bib0036","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ygyno.2014.02.030","article-title":"Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers","volume":"133","author":"Holman","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2020.09.020_bib0037","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ygyno.2018.04.564","article-title":"Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: a pilot study in women with BRCA1\/2 mutations","volume":"150","author":"Nebgen","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2020.09.020_bib0038","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/AOG.0b013e3182783c2f","article-title":"Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers","volume":"121","author":"Kwon","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2020.09.020_bib0039","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1186\/s12885-015-1597-y","article-title":"Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1\/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study","volume":"15","author":"Harmsen","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jmig.2020.09.020_bib0040","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ygyno.2019.04.055","article-title":"WISP: a prospective, multi-center trial of salpingectomy with delayed oophorectomy versus risk reducing salpingo-oophorectomy in women at increased risk for hereditary ovarian cancer","volume":"154","author":"Lu","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2020.09.020_bib0041","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ygyno.2019.04.054","article-title":"Worry and regret in the prospective multicentre TUBA study in BRCA1\/2 mutation carriers","volume":"154","author":"Steenbeek","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2020.09.020_bib0042","doi-asserted-by":"crossref","first-page":"dju410","DOI":"10.1093\/jnci\/dju410","article-title":"Ovarian cancer risk after salpingectomy: a nationwide population-based study","volume":"107","author":"Falconer","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jmig.2020.09.020_bib0043","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/aje\/kwf048","article-title":"Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study","volume":"156","author":"Riman","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jmig.2020.09.020_bib0044","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/AOG.0000000000000630","article-title":"Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategy","volume":"125","author":"Kwon","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2020.09.020_bib0045","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/1471-0528.14182","article-title":"Impact of opportunistic salpingectomy on anti-M\u00fcllerian hormone in patients undergoing laparoscopic hysterectomy: a multicentre randomised controlled trial","volume":"124","author":"Song","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.jmig.2020.09.020_bib0046","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ygyno.2013.03.023","article-title":"Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere","volume":"129","author":"Morelli","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2020.09.020_bib0047","doi-asserted-by":"crossref","first-page":"471.e1","DOI":"10.1016\/j.ajog.2014.01.003","article-title":"Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention","volume":"210","author":"McAlpine","year":"2014","journal-title":"Am J Obstet Gynecol"}],"container-title":["Journal of Minimally Invasive Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553465020310827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553465020310827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:42:53Z","timestamp":1761558173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553465020310827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1553465020310827"],"URL":"https:\/\/doi.org\/10.1016\/j.jmig.2020.09.020","relation":{},"ISSN":["1553-4650"],"issn-type":[{"value":"1553-4650","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salpingectomy for the Risk Reduction of Ovarian Cancer: Is It Time for a Salpingectomy-alone Approach?","name":"articletitle","label":"Article Title"},{"value":"Journal of Minimally Invasive Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmig.2020.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 AAGL. All rights reserved.","name":"copyright","label":"Copyright"}]}}